Atlas Venture Life Science Advisors »

Q32 Bio shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $38M 2.1M 17.95
2024-03-31 $36M 2.1M 17.04

More positions owned by Atlas Venture Life Science Advisors

Dyne Therapeutics Common Stock (DYN)
Kymera Therapeutics Common Stock (KYMR)
Third Harmonic Bio Common Stock (THRD)
Disc Medicine Common Stock (IRON)
Day One Biopharmaceuticals Common Stock (DAWN)
Korro Bio Common Stock (KRRO)
Q32 Bio Common Stock (QTTB)
Generation Bio Common Stock (GBIO)
Vigil Neuroscience Common Stock (VIGL)
Replimune Group Common Stock (REPL)
Ikena Oncology Common Stock (IKNA)
Tectonic Therapeutics Common Stock (TECX)
Dianthus Therapeutics Common Stock (DNTH)
Aerovate Therapeutics Common Stock (AVTE)
Spero Therapeutics Common Stock (SPRO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
BlackRock
BlackRock
Arch Venture Corp
Eventide Asset Management
Harvard Management Company
Vanguard Group
Geode Capital Management
Woodline Partners
State Street Corporation
Point72 Asset Management
Platinum Investment Mangement
Ensign Peak Advisors

View all funds holding Q32 Bio